Guidelines on cardiovascular risk assessment and management

European Heart Journal, Supplement

Volumn 7, Issue L, 2005, Pages

  Wood, David A ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Cardiovascular disease; Guidelines; Lifestyle modification; Obesity; SCORE; Treatment targets

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTERIAL PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CONFERENCE PAPER; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GLUCOSE BLOOD LEVEL; HEART INFARCTION PREVENTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MORBIDITY; MORTALITY; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; THROMBOGENICITY; WEIGHT REDUCTION;

EID: 27744595680     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sui079     Document Type: Conference Paper

References (9)

1. European Society of Cardiology. Cardiovascular Diseases in Europe: Euro Heart Survey and National Registries of Cardiovascular Diseases and Patient Management. 2004 Sophia Antipolis, France: ESC.
2. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003;10(Suppl. 1):S1-S78.
3. Conroy RM, Pyorala K, Fitzgerald AP et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
4. Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
5. EUROASPIRE Study Group. EUROASPIRE: a European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997;18:1569-1582.
6. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Eur Heart J 2001;22:554-572.
7. EUROASPIRE Study Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001;357:995-1001.
8. De Bacquer D, De Backer G, Cokkinos D et al. for the EUROASPIRE II study group. Overweight and obesity in patients with established coronary heart disease: are we meeting the challenge? Eur Heart J 2004;25:121-128.
9. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, http://www.idf.org (14 April 2005).